Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
Disclosed herein are novel formulations containing relacorilant ((R)-(1-(4-fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone) that are suitable for administration, including oral administration,...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
10.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Disclosed herein are novel formulations containing relacorilant ((R)-(1-(4-fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone) that are suitable for administration, including oral administration, to patients suffering from disorders amenable to treatment by glucocorticoid receptor modulators (GRMs). Single unit dosage forms comprise softgel capsules containing these formulations. Such softgel capsules may contain, e.g., relacorilant formulations containing 25 milligrams (mg), 50 mg, 100 mg, 200 mg, 300 mg, 400 mg, 500 mg, or other amounts of relacorilant. These novel formulations and single unit dosage forms may be used to treat diseases and disorders including Cushing's syndrome, Cushing's Disease, and other disorders. |
---|---|
AbstractList | Disclosed herein are novel formulations containing relacorilant ((R)-(1-(4-fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone) that are suitable for administration, including oral administration, to patients suffering from disorders amenable to treatment by glucocorticoid receptor modulators (GRMs). Single unit dosage forms comprise softgel capsules containing these formulations. Such softgel capsules may contain, e.g., relacorilant formulations containing 25 milligrams (mg), 50 mg, 100 mg, 200 mg, 300 mg, 400 mg, 500 mg, or other amounts of relacorilant. These novel formulations and single unit dosage forms may be used to treat diseases and disorders including Cushing's syndrome, Cushing's Disease, and other disorders. |
Author | SCOTT, Ian LEMONS, Travis ARBOLEDA, Stephen ALSMEYER, Yan CHIA, Yip-Fong |
Author_xml | – fullname: ALSMEYER, Yan – fullname: CHIA, Yip-Fong – fullname: SCOTT, Ian – fullname: ARBOLEDA, Stephen – fullname: LEMONS, Travis |
BookMark | eNqNjTsOwjAQBV1Awe8OlmiJlJ-QKCMEoqSAOlqcDbFwdiN7XcDpccEBqF4zM2-pZsSEC_W4DuBHMBjFGnC6Zz9GB2KZgjZMApYsPbVHB4a9dUCy06AHFPQM_u2yF0pK6T4G7DR8oMMUspTsceJI3VrNe3ABN79dqe35dDteMpy4xTClc0Jpm3uZF4c6r_Ny3xTVf9QXTrZBxg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | AU2019404026A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU2019404026A13 |
IEDL.DBID | EVB |
IngestDate | Fri Aug 30 05:41:19 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU2019404026A13 |
Notes | Application Number: AU20190404026 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210610&DB=EPODOC&CC=AU&NR=2019404026A1 |
ParticipantIDs | epo_espacenet_AU2019404026A1 |
PublicationCentury | 2000 |
PublicationDate | 20210610 |
PublicationDateYYYYMMDD | 2021-06-10 |
PublicationDate_xml | – month: 06 year: 2021 text: 20210610 day: 10 |
PublicationDecade | 2020 |
PublicationYear | 2021 |
RelatedCompanies | CORCEPT THERAPEUTICS INCORPORATED |
RelatedCompanies_xml | – name: CORCEPT THERAPEUTICS INCORPORATED |
Score | 3.3436856 |
Snippet | Disclosed herein are novel formulations containing relacorilant... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210610&DB=EPODOC&locale=&CC=AU&NR=2019404026A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8NAEB1KFfWmVfGjyoKSk8E22U2bQ5E2aSlC2yCt9FbysaHBkJYmRfTXOxNTzam3kMCQDDvZebNv3gA8amZb81siUF3MiVSMRKm29VCoLWGKADFuk7t0ojsaG8MZf52LeQXiXS9MrhP6mYsjYkT5GO9Z_r9e_xex7JxbmT57Ed5avQymHVsp0LFGAKeh2L1O35nYE0uxLESSyviNSoEmxwWrGV3ESgeUSJPSfv-9R30p6_KmMjiFQwftJdkZVGRSg2NrN3utBkej4sgbL4voS8_Bc5blAjSjfLOYvpUy4pz_Tntg1J-CoDKK0WtPzGVLorys3M1XrH5IEt9m4TaVAXO_3UCioShhxCynAUsX8DDoT62hii-7-PPNojsrf5l-CdUEzVwBCzyDt2SD-9IMuc-5qUvqIxUeSfAJ07-G-j5LN_sf38IJeZs4U81GHarZZivvcHfOvPvcqT_3p5SN |
link.rule.ids | 230,309,786,891,25594,76904 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QNOJNUeMDdRNNTzZCu9vSAzHQQlB5xYDhRvpYArEphJYY_fXO1KKcuDXbZNKd7HT3m_3mG4B7zapqvikC1cUzkYqRKNWqPhWqKSwRIMatcJdudLs9oz3iL2MxzkG4qYVJdUI_U3FEjCgf4z1J_9fL_ySWk3Ir40dvjkOLp9aw5igZOtYI4JQVp1FrDvpO31ZsG5Gk0nujVKDFccFqRh2x0p6JoJCU9pvvDapLWW5vKq0j2B-gvSg5hpyMilCwN73XinDQza688TGLvvgEvMFsOwHN6LyZdd-KGXHOf7s9MKpPQVA5D9FrD8xlM6K8LNzVV6h-SBLfZtN1LAPmfruBREPziBGznBosncJdqzm02yp-7OTPN5P6aHtm-hnkIzRzDizwDG7KMvelNeU-55YuqY5UeCTBJyz_Akq7LF3ufn0Lhfaw25l0nnuvV3BInif-VKVcgnyyWstr3KkT7yZ18A8RL5d4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Pharmaceutical+formulations+containing+relacorilant%2C+a+heteroaryl-ketone+fused+azadecalin+compound&rft.inventor=ALSMEYER%2C+Yan&rft.inventor=CHIA%2C+Yip-Fong&rft.inventor=SCOTT%2C+Ian&rft.inventor=ARBOLEDA%2C+Stephen&rft.inventor=LEMONS%2C+Travis&rft.date=2021-06-10&rft.externalDBID=A1&rft.externalDocID=AU2019404026A1 |